Standard BioTools
LAB on XNAS, Standard BioTools Inc.
Measures activity, not value. Not investment advice.
New positions, last 12 months
81
+16% vs the 12 months before
Positions closed, last 12 months
124
+94% vs the 12 months before
Net, last 12 months
-43
new positions minus positions closed
Sharp changes
3
many funds opening a new position
What usually follows Change in institutional holders was not followed by a clear share-price difference over the next 6 months. No relationship found How we measured it
Largest holders over the last 8 quarters
Shares reported on Form 13F at each quarter end; the 10 largest holders of Q3 2026. "–": no full report for that quarter (not filed yet, or positions kept confidential)| Institution | Trend | Q4 2024 | Q1 2025 | Q2 2025 | Q3 2025 | Q4 2025 | Q1 2026 | Q2 2026 | Q3 2026 |
|---|---|---|---|---|---|---|---|---|---|
| Casdin Capital, LLC | 71.3M | 76.1M | 76.1M | 77.6M | 88.8M | 88.8M | 88.8M | 88.8M | |
| Viking Global Investors LP | 58.7M | 58.7M | 58.7M | 58.7M | 58.7M | 58.7M | 58.7M | 58.7M | |
| Long Focus Capital Management, LLC | 0 | 6.7M | 10.1M | 11.4M | 12.7M | 16.0M | 23.5M | 25.3M | |
| Mak Capital One LLC | 0 | 2.8M | 5.6M | 15.9M | 19.3M | 26.2M | 28.8M | 25.0M | |
| Vanguard Capital Management LLC | – | – | – | – | – | 12.8M | 12.3M | 12.5M | |
| BlackRock, Inc. | 24.9M | 24.6M | 24.8M | 24.9M | 25.5M | 24.8M | 8.3M | 8.3M | |
| Hollow Brook Wealth Management LLC | 5.5M | 5.6M | 5.6M | 5.8M | 5.6M | 5.7M | 5.5M | 5.2M | |
| Qube Research & Technologies Ltd | 491K | 420K | 441K | 283K | 217K | 704K | 4.8M | 4.9M | |
| Neuberger Berman Group LLC | 4.6M | 4.5M | 4.5M | 4.7M | 4.6M | 4.7M | 5.0M | 4.3M | |
| D. E. Shaw & Co., Inc. | 0 | 0 | 0 | 0 | 0 | 199K | 2.8M | 4.0M |
Form 13F holdings by quarter end.
See the numbers
| Quarter of Jul 2026: new positions 8, positions closed 41 |
| Quarter of Apr 2026: new positions 39, positions closed 49 |
| Quarter of Jan 2026: new positions 18, positions closed 22 |
| Quarter of Oct 2025: new positions 16, positions closed 12 |
| Quarter of Jul 2025: new positions 9, positions closed 16 |
| Quarter of Apr 2025: new positions 24, positions closed 13 |
| Quarter of Jan 2025: new positions 21, positions closed 17 |
| Quarter of Oct 2024: new positions 16, positions closed 18 |
| Quarter of Jul 2024: new positions 16, positions closed 21 |
| Quarter of Apr 2024: new positions 31, positions closed 34 |
| Quarter of Jan 2024: new positions 67, positions closed 12 |
| Quarter of Oct 2023: new positions 21, positions closed 11 |
| Quarter of Jul 2023: new positions 14, positions closed 8 |
| Quarter of Apr 2023: new positions 15, positions closed 13 |
| Quarter of Jan 2023: new positions 11, positions closed 14 |
| Quarter of Oct 2022: new positions 10, positions closed 11 |
| Quarter of Jul 2022: new positions 4, positions closed 22 |
| Quarter of Apr 2022: new positions 24, positions closed 35 |
| Quarter of Jan 2022: new positions 8, positions closed 23 |
| Quarter of Oct 2021: new positions 17, positions closed 20 |
| Quarter of Jul 2021: new positions 19, positions closed 10 |
| Quarter of Apr 2021: new positions 8, positions closed 31 |
| Quarter of Jan 2021: new positions 24, positions closed 30 |
| Quarter of Oct 2020: new positions 31, positions closed 26 |
| Quarter of Jul 2020: new positions 39, positions closed 19 |
| Quarter of Apr 2020: new positions 27, positions closed 17 |
| Quarter of Jan 2020: new positions 14, positions closed 12 |
| Quarter of Oct 2019: new positions 9, positions closed 36 |
| Quarter of Jul 2019: new positions 20, positions closed 28 |
| Quarter of Apr 2019: new positions 23, positions closed 22 |
| Quarter of Jan 2019: new positions 45, positions closed 16 |
| Quarter of Oct 2018: new positions 29, positions closed 9 |
| Quarter of Jul 2018: new positions 5, positions closed 10 |
| Quarter of Apr 2018: new positions 11, positions closed 11 |
| Quarter of Jan 2018: new positions 11, positions closed 8 |
| Quarter of Oct 2017: new positions 8, positions closed 10 |
| Quarter of Jul 2017: new positions 5, positions closed 6 |
| Quarter of Apr 2017: new positions 8, positions closed 8 |
| Quarter of Jan 2017: new positions 11, positions closed 9 |
| Quarter of Oct 2016: new positions 9, positions closed 22 |
What the numbers say
- New positions: 8 vs positions closed: 41 in the quarter from 1 Jul 2026.
- Net new institutional positions over 12 months: -43, number 805 of 820 Health Care companies with data (median 14).
- 3 sharp changes in all loaded history (many funds opening a new position).
- 13F moves in the last four quarters: the largest is added, 169 (32%).
See the numbers
| Added | 169 (32%) |
| Cut | 158 (30%) |
| Closed | 124 (23%) |
| Opened | 81 (15%) |
Every measure from this source
5 years, by the period each figure describes
Sharp changes
3 in all loaded history, strongest first
Standard BioTools saw 67 13F filers open a new position in the quarter ended 31 Mar 2024, 5.6× the same quarter last year.
Same quarter last year: 12; its normal quarter is 13.
See the evidence
- This period
- 67 (the quarter ended 31 Mar 2024)
- Normal quarter (median of 8 earlier)
- 13
- Typical spread (median absolute deviation)
- 4
- How far from its usual level
- +9.1
- Same quarter last year
- 12
- History used
- 3,835 days
Fires when the period is at least 3.5 robust standard deviations above the company's own median, with 6+ earlier periods, 730+ days of history and a value of at least 20.
Check it at the source: SEC Form 13F data sets.
Standard BioTools saw 45 13F filers open a new position in the quarter ended 31 Mar 2019, 4.1× the same quarter last year.
Same quarter last year: 11; its normal quarter is 10.
See the evidence
- This period
- 45 (the quarter ended 31 Mar 2019)
- Normal quarter (median of 8 earlier)
- 10
- Typical spread (median absolute deviation)
- 2
- How far from its usual level
- +11.7
- Same quarter last year
- 11
- History used
- 2,008 days
Fires when the period is at least 3.5 robust standard deviations above the company's own median, with 6+ earlier periods, 730+ days of history and a value of at least 20.
Check it at the source: SEC Form 13F data sets.
Standard BioTools saw 29 13F filers open a new position in the quarter ended 31 Dec 2018, 3.2× the same quarter last year.
Same quarter last year: 9; its normal quarter is 9.
See the evidence
- This period
- 29 (the quarter ended 31 Dec 2018)
- Normal quarter (median of 8 earlier)
- 9
- Typical spread (median absolute deviation)
- 2.5
- How far from its usual level
- +5.4
- Same quarter last year
- 9
- History used
- 1,918 days
Fires when the period is at least 3.5 robust standard deviations above the company's own median, with 6+ earlier periods, 730+ days of history and a value of at least 20.
Check it at the source: SEC Form 13F data sets.
The records
Newest first, by the day each became public